,i  #aaeth ,,congress  #b;d ,session    
,h4 ,r4 #edhb  ,,in ,,the ,,house ,,of  
,,representatives  ,april #ab1 #bjah    
,mr4 ,bacon introduced the following    
bill2 which was referred to the         
,committee on ,armed ,services  ,a      
,,bill  ,to direct the ,assistant       
,secretary of ,defense for ,health      
,affairs to develop a plan for          
countering emerging and deliberate      
infectious disease threats1 and for     
other purposes4  #a4 ,short title ,this 
,act may be cited as the ,military      
,biodefense ,readiness and ,protection  
,act of #bjah4  #b4 ,findings ,congress 
finds the following3  7#a7 ,the #bjad   
,ebola crisis demonstrated the need for 
the ,department of ,defense to provide a
 prompt and efficient response to an    
outbreak of a highly infectious disease4
  7#b7 ,a future outbreak of an         
infectious disease is all but certain   
and the lessons learned from the #bjad  
,ebola crisis are directly applicable to
 the next crisis4  7#c7 ,it is critical 

that the ,department of ,defense take   
immediate action to ensure the joint    
force is protected from emerging        
infectious diseases and the potential   
deliberate use of infectious diseases   
threats1 while also being prepared to   
conduct military operations in areas of 
increased risk as part of an            
international response to a future      
public health emergency4  7#d7 ,to      
ensure mission effectiveness and force  
protection1 the ,department of ,defense 
should work closely with the ,department
 of ,state and the ,department of       
,health and ,human ,services before1    
during1 and after an infectious disease 
outbreak4  #c4 ,plan for countering     
emerging and deliberate infectious      
disease threats  7a7 ,plan ,the         
,assistant ,secretary of ,defense for   
,health ,affairs1 in coordination with  
the ,assistant ,secretary of ,health and
 ,human ,services for ,preparedness and 
,response1 and in consultation with the 
,director of the ,defense ,advanced     

,research ,program ,agency1 the         
,director of the ,office of ,net        
,assessment1 and the head of the        
,defense ,innovation ,unit              
,experimental1 shall develop a plan for 
countering emerging and deliberate      
infectious disease threats to ensure    
joint force health protection and the   
ability of the ,armed ,forces to conduct
 operations in an area subject to an    
emerging infectious disease threat4  7b7
 ,matters included  7#a7 ,focus areas   
,the plan developed under subsection 7a7
 shall address the following3  7,a7     
,detection and management of patients   
with emerging and high-consequence      
infections identified in the ,r,d       
,blueprint ,priority ,disease ,list of  
the ,world ,health ,organization1       
including novel emerging unknown        
pathogens classified as ,disease ,x4    
7,b7 ,improved point-of-care1           
point-of-need1 and next-generation early
 detection diagnostics linked to disease
 surveillance1 response planning1 and   

information sharing networks4  7,c7     
,evidence-based1 best-practice clinical 
management protocols that include       
pre-specified data collection and       
analysis plans that are specifically    
tailored for enhanced survival of       
infectious disease casualties and       
near-time data generation in            
low-resource conditions4  7,d7 ,enhanced
 infection prevention and control       
standards1 guidelines1 and training1    
including new technologies for          
protecting health care workers4  7,e7   
,improved capability for medical        
evacuation of patients with             
high-consequence infections4  7,f7      
,infectious disease emergency response  
teams to provide supplemental expertise 
and capability for dangerous pathogen   
infections patient management and       
movement in forward environments or in  
higher-level military medical treatment 
facilities4  7,g7 ,acceleration of      
research and development of medical     
countermeasures1 therapeutics1 and      

vaccines against high-consequence       
infections1 including the development of
 clinical trial networks capable of     
generating critical supplemental human  
data in support of licensure            
applications administered by the ,food  
and ,drug ,administration4  7,h7        
,coordinated and rapid manufacturing    
response capacity and capabilities1     
using regional1 flexible1 scalable      
technologies and facilities1 leveraging 
successful medical countermeasure       
development and manufacturing models    
implemented in the ,department of       
,health and ,human ,services and other  
departments of the ,federal ,government4
  7#b7 ,scope ,for each area specified  
in paragraph 7#a71 the plan shall       
include-- 7,a7 milestones and actions   
that can be carried out in both the     
one-year and five-year timeframes       
following the date of the plan1         
including with respect to operations1   
training1 equipping1 research1 and      
technology development2  7,b7 an        

identification of the element of the    
,department of ,defense to lead the     
,department in carrying out such        
actions2  7,c7 the budget levels and    
priorities to carry out such actions2   
and  7,d7 an identification of          
opportunities to leverage the experience
 of the ,department of ,state and the   
,department of ,health and ,human       
,services4  7c7 ,submission ,not later  
than #ahj days after the date of the    
enactment of this ,act1 the ,assistant  
,secretary of ,defense shall submit to  
,congress the plan developed under      
subsection 7a71 including identification
 of any legislative action or           
administrative action required to       
implement such plan4